Back to company

Pharmyn ApS: Financial statements 2021

CVR: 37133892

Pharmyn ApS (CVR 37133892) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 12,488 and a net result of DKK 12,244 compared with DKK -20,728 the year before. Equity amounted to DKK 33,894. The solvency ratio was 76.9%.

Gross Profit
12,488 kr.
Profit/Loss
12,244 kr.
Equity
33,894 kr.
Total Assets
44,067 kr.
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2021-12 t.12 t.34 t.0
2020--20 t.-21 t.22 t.0
2019-108042 t.1
2018-2888842 t.0
2017--4 t.-4 t.42 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like Pharmyn ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2021

Pharmyn ApS: The 2020 annual report is outApr 7, 2021

Pharmyn ApS has published its annual report for 2020. Gross profit came to DKK -20,104, and the net result was DKK -20,728.

About Pharmyn ApS

Pharmyn ApS is a Danish company of the type Anpartsselskab based in Kolding, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Henrik Lund Uth. The company is owned by Henrik Lund Uth. In 2025, the company reported a gross profit of DKK -12,457 and a net result of DKK -12,409 compared with DKK 6,701 the year before. Equity amounted to DKK 18,662.